Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

EANM procedure guidelines for 131I-meta-iodobenzylguanidine (131I-mIBG) therapy.

Giammarile F, Chiti A, Lassmann M, Brans B, Flux G; EANM.

Eur J Nucl Med Mol Imaging. 2008 May;35(5):1039-47. doi: 10.1007/s00259-008-0715-3.

PMID:
18274745
2.

Guidelines for 131I-meta-iodobenzylguanidine therapy.

[No authors listed]

Eur J Nucl Med Mol Imaging. 2003 Mar;30(3):BP23-6. No abstract available.

PMID:
12723562
4.

131I/123I-metaiodobenzylguanidine (mIBG) scintigraphy: procedure guidelines for tumour imaging.

Bombardieri E, Giammarile F, Aktolun C, Baum RP, Bischof Delaloye A, Maffioli L, Moncayo R, Mortelmans L, Pepe G, Reske SN, Castellani MR, Chiti A; European Association for Nuclear Medicine.

Eur J Nucl Med Mol Imaging. 2010 Dec;37(12):2436-46. doi: 10.1007/s00259-010-1545-7.

PMID:
20644928
5.

Minimizing nuclear medicine technologist radiation exposure during 131I-MIBG therapy.

Turpin BK, Morris VR, Lemen L, Weiss BD, Gelfand MJ.

Health Phys. 2013 Feb;104(2 Suppl 1):S43-6. doi: 10.1097/HP.0b013e318277659a.

PMID:
23287519
6.

131I-MIBG therapy of neural crest tumours (review).

Troncone L, Rufini V.

Anticancer Res. 1997 May-Jun;17(3B):1823-31. Review.

PMID:
9179240
7.
8.

Treatment of metastatic carcinoid tumours, phaeochromocytoma, paraganglioma and medullary carcinoma of the thyroid with (131)I-meta-iodobenzylguanidine [(131)I-mIBG].

Mukherjee JJ, Kaltsas GA, Islam N, Plowman PN, Foley R, Hikmat J, Britton KE, Jenkins PJ, Chew SL, Monson JP, Besser GM, Grossman AB.

Clin Endocrinol (Oxf). 2001 Jul;55(1):47-60.

PMID:
11453952
9.
10.

[131I meta-iodobenzylguanidine in combination with hyperbaric oxygen therapy in the treatment of prognostically high-risk forms of neuroblastoma].

Stanková J, Kavan P, Krízová H, Hermanská E, Dosel P, Sázel M.

Cas Lek Cesk. 2001 Jan 19;140(1):13-7. Czech.

PMID:
11242978
11.

[¹³¹I]Metaiodobenzylguanidine therapy in neural crest tumors: varying outcome in different histopathologies.

Rachh SH, Abhyankar S, Basu S.

Nucl Med Commun. 2011 Dec;32(12):1201-10. doi: 10.1097/MNM.0b013e32834bad97.

PMID:
21968432
12.

Noradrenaline transporter gene transfer for radiation cell kill by 131I meta-iodobenzylguanidine.

Boyd M, Cunningham SH, Brown MM, Mairs RJ, Wheldon TE.

Gene Ther. 1999 Jun;6(6):1147-52.

13.

Comparison of [123I]MIBG and [131I]MIBG for imaging of neuroblastoma and other neural crest tumors.

Liu B, Zhuang H, Servaes S.

Q J Nucl Med Mol Imaging. 2013 Mar;57(1):21-8. Review.

PMID:
23474632
14.

Specific binding and uptake of 131I-MIBG and 111In-octreotide in metastatic paraganglioma--tools for choice of radionuclide therapy.

Spetz J, Dalmo J, Nilsson O, Wängberg B, Ahlman H, Forssell-Aronsson E.

Horm Metab Res. 2012 May;44(5):400-4. doi: 10.1055/s-0032-1311603. Epub 2012 May 7.

PMID:
22566195
15.

[Guideline draft of appropriate use of 131I-MIBG for internal radiotherapy of neuroendocrine tumors].

Nakajo M, Yoshinaga K, Oriuchi N, Kinuya S, Yokoyama K, Yamaguchi T; Drafting Committee for Guideline of Internal Radiotherapy with 131I-MIBG; Japanese Society of Nuclear Medicine in Oncology and Immunology; Japanese Society of Nuclear Medicine.

Kaku Igaku. 2008 Feb;45(1):suppl 1-40. Japanese.

PMID:
19594094
16.

131I/123I-metaiodobenzylguanidine (MIBG) scintigraphy: procedure guidelines for tumour imaging.

Bombardieri E, Aktolun C, Baum RP, Bishof-Delaloye A, Buscombe J, Chatal JF, Maffioli L, Moncayo R, Mortelmans L, Reske SN.

Eur J Nucl Med Mol Imaging. 2003 Dec;30(12):BP132-9. No abstract available.

PMID:
14989227
17.

131I-Metaiodobenzylguanidine therapy in children with advanced neuroblastoma.

DuBois SG, Matthay KK.

Q J Nucl Med Mol Imaging. 2013 Mar;57(1):53-65. Review.

PMID:
23474635
18.

Nothing but NET: a review of norepinephrine transporter expression and efficacy of 131I-mIBG therapy.

Streby KA, Shah N, Ranalli MA, Kunkler A, Cripe TP.

Pediatr Blood Cancer. 2015 Jan;62(1):5-11. doi: 10.1002/pbc.25200. Epub 2014 Aug 30. Review.

19.

Comparison of radiohaloanalogues of meta-iodobenzylguanidine (MIBG) for a combined gene- and targeted radiotherapy approach to bladder carcinoma.

Fullerton NE, Boyd M, Ross SC, Pimlott SL, Babich J, Kirk D, Zalutsky MR, Mairs RJ.

Med Chem. 2005 Nov;1(6):611-8.

PMID:
16787344
20.

Meta-[radioiodinated]iodobenzylguanidine.

The MICAD Research Team.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2007 May 3 [updated 2007 Jul 3].

Supplemental Content

Support Center